Helicobacter pylori cytotoxin-associated genotype and gastric precancerous lesions

Journal of the National Cancer Institute

Volumn 99, Issue 17, 2007, Pages 1328-1334

  Plummer, Martyn ^a   van Doorn, Leen Jan ^b   Franceschi, Silvia ^a   Kleter, Bernhard ^b   Canzian, Federico ^c   Vivas, Jorge ^d   Lopez, Gladys ^d   Colin, Didier ^a   Muñoz, Nubia ^e   Kato, Ikuko ^f,g  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b DDL DIAGNOSTIC LABORATORY   (Netherlands)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d Cancer Control Center of the Tachira State   (Venezuela)

^e Instituto Nacional de Cancerología   (Colombia)

^f KARMANOS CANCER INSTITUTE   (United States)

^g WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; CAGA PROTEIN;

ADULT; AGED; ARTICLE; CANCER PREVENTION; CHRONIC GASTRITIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; DYSPLASIA; GENETIC VARIABILITY; GENOTYPE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MARKER GENE; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; SEROLOGY; STOMACH BIOPSY; STOMACH CANCER; VENEZUELA; VITAMIN SUPPLEMENTATION;

ADULT; AGED; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BIOPSY; CROSS-SECTIONAL STUDIES; DNA, BACTERIAL; GASTRITIS; GENOTYPE; HELICOBACTER PYLORI; HUMANS; MIDDLE AGED; PRECANCEROUS CONDITIONS; STOMACH NEOPLASMS;

EID: 34548599897     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djm120     Document Type: Article

References (33)

1. Blaser MJ. Helicobacter pylori and gastric diseases. BMJ 1998; 316:1507-10.
2. Megraud F, Brassens-Rabbe MP, Denis F, Belbouri A, Hoa DQ. Seroepidemiology of Campylobacter pylori infection in various populations. J Clin Microbiol. 1989;27:1870-3.
3. EUROGAST. Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. The EUROGAST Study Group. Gut 1993;34:1672-6.
4. IARC. IARC Monographs on the evaluation of carcinogenic risks to humans, volume 61: Schistosomes, liver flukes and Helicobacter pylori. Lyon, France: IARC; 1994.
5. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006;118:3030-44.
6. Achtman M, Azuma T, Berg DE, Ito Y, Morelli G, Pan ZJ, et al. Recombination and clonal groupings within Helicobacter pylori from different geographical regions. Mol Microbiol 1999;32:459-70.
7. Hatakeyama M. Helicobacter pylori CagA - a bacterial intruder conspiring gastric carcinogenesis. Int J Cancer 2006;119:1217-23.
8. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995;55:2111-5.
9. Kuipers EJ, Perez-Perez GI, Meuwissen SG, Blaser MJ. Helicobacter pylori and atrophic gastritis: Importance of the cagA status. J Natl Cancer Inst 1995;87:1777-80.
10. Correa P. Human gastric carcinogenesis: A multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992;52:6735-40.
11. Plummer M, Vivas J, Lopez G, Bravo JC, Peraza S, Carillo E, et al. Chemoprevention of precancerous gastric lesions by antioxidant vitamin supplementation: A randomised trial in a high-risk population. J Natl Cancer Inst 2007;99:137-46.
12. Muñoz N, Kato I, Peraza S, Lopez G, Carrillo E, Ramirez H, et al. Prevalence of precancerous lesions of the stomach in Venezuela. Cancer Epidemiol Biomarkers Prev 1996;5:41-6.
13. Filipe MI, Jass JR. Intestinal metaplasia subtypes and cancer risks. In: Filipe MI, Jass JR, editors. Gastric carcinoma. Edinburgh: Churchill Livingstone; 1986. p. 87-115.
14. van Doorn LJ, Figueiredo C, Sanna R, Pena S, Midolo P, Ng EK, et al. Expanding allelic diversity of Helicobacter pylori vacA. J Clin Microbiol 1998;36:2597-603.
15. van Doorn LJ, Figueiredo C, Rossau R, Jannes G, van Asbroek M, Sousa JC, et al. Typing of Helicobacter pylori vacA gene and detection of cagA gene by PCR and reverse hybridization. J Clin Microbiol 1998;36:1271-6.
16. van Doorn LJ, Figueiredo C, Sanna R, Blaser MJ, Quint WG. Distinct variants of Helicobacter pylon cagA are associated with vacA subtypes. J Clin Microbiol 1999;37:2306-11.
17. Plummer M. Improved estimates of floating absolute risk. Stat Med 2004;23:93-104.
18. Plummer M, Vivas J, Fauchere JL, Del Giudice G, Pena AS, Ponzetto A, et al. Helicobacter pylori and stomach cancer: A case-control study in Venezuela. Cancer Epidemiol Biomarkers Prev 2000;9:961-5.
19. Ghose C, Perez-Perez GI, van Doorn LJ, Dominguez-Bello MG, Blaser MJ. High frequency of gastric colonization with multiple Helicobacter pylori strains in Venezuelan subjects. J Clin Microbiol 2005;43: 2635-41.
20. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: A combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001;49:347-53.
21. Rocha GA, Guerra JB, Rocha AM, Saraiva IE, da Silva DA, de Oliveira CA, et al. IL1RN polymorphic gene and cagA-positive status independently increase the risk of noncardia gastric carcinoma. Int J Cancer 2005;115:678-83.
22. Figueiredo C, Machado JC, Pharoah P, Seruca R, Sousa S, Carvalho R, et al. Helicobacter pylori and interleukin 1 genotyping: An opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 2002;94:1680-7.
23. Rugge M, Busatto G, Cassaro M, Shiao YH, Russo V, Leandro G, et al. Patients younger than 40 years with gastric carcinoma: Helicobacter pylori genotype and associated gastritis phenotype. Cancer 1999;85: 2506-11.
24. Quintero E, Pizarro MA, Rodrigo L, Pique JM, Lanas A, Ponce J, et al. Association of Helicobacter pylori-related distal gastric cancer with the HLA class II gene DQB10602 and cagA strains in a southern European population. Helicobacter 2005;10:12-21.
25. Nogueira C, Figueiredo C, Carneiro F, Gomes AT, Barreira R, Figueira P, et al. Helicobacter pylori genotypes may determine gastric histopathology. Am J Pathol 2001;158:647-54.
26. Blaser MJ. Allelic variation in Helicobacter pylori: Progress but no panacea. Gut 1999;45:477-8.
27. El Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;404:398-402.
28. Kato I, van Doorn LJ, Canzian F, Plummer M, Franceschi S, Vivas J, et al. Host-bacterial interaction in the development of gastric precancerous lesions in a high risk population for gastric cancer in Venezuela. Int J Cancer 2006;119:1666-71.
29. Kato I, Canzian F, Plummer M, Franceschi S, van Doorn LJ, Vivas J, et al. Polymorphisms in genes related to bacterial lipopolysaccharide/ peptidoglycan signalling and gastric precancerous lesions in a population at high risk for gastric cancer. Dig Dis Sci 2007;52:254-61.
30. Kato I, Canzian F, Franceschi S, Plummer M, van Doorn LJ, Lu Y, et al. Genetic polymorphisms in anti-inflammatory cytokine signaling and the prevalence of gastric precancerous lesions in Venezuela. Cancer Causes Control 2006;17:1183-91.
31. Bjorkholm B, Falk P, Engstrand L, Nyren O. Helicobacter pylori: resurrection of the cancer link. J Intern Med 2003;253:102-19.
32. Ekstrom AM, Held M, Hansson LE, Engstrand L, Nyren O. Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology 2001;121:784-91.
33. Brenner H, Arndt V, Stegmaier G, Ziegler H, Rothenbacher D. Is Helicobacter pylori infection a necessary condition for noncardia gastric cancer? Am J Epidemiol 2004;159:252-8.